financetom
Business
financetom
/
Business
/
Stellantis says Illinois investment plans delayed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis says Illinois investment plans delayed
Aug 20, 2024 6:37 AM

Aug 20 (Reuters) - Stellantis ( STLA ) said on Tuesday

its planned investments at Belvidere, Illinois, will be delayed

but it is committed to moving forward and is not in violation

of its union contract.

On Monday, the United Auto Workers union said some of its

local units representing tens of thousands of workers at

Stellantis ( STLA ) were preparing to file grievances and could launch a

nationwide strike, accusing the automaker of not honoring

production commitments.

Chrysler-parent Stellantis ( STLA ) said on Tuesday it had told the

UAW of the delay "but firmly stands by its commitment" saying

the new timetable is needed "to ensure the company's future

competitiveness and sustainability, which are necessary to

preserve U.S. manufacturing jobs."

The UAW did not immediately comment.

Stellantis ( STLA ) agreed to build a new $3.2 billion battery plant

and invest $1.5 billion in a new mid-size truck factory in

Belvidere and add 5,000 total U.S. jobs by 2028 as part of a new

contract deal, the UAW said in November.

UAW President Shawn Fain referred to the issue during

remarks at the Democratic National Convention on Monday night.

"Let me be clear: Stellantis ( STLA ) must keep the promises they

made to America and our union contract. And the UAW will take

whatever action necessary at Stellantis ( STLA ) or any other corporation

to stand up and hold corporate America accountable," he said.

"(Stellantis ( STLA )) has not violated the commitments made in the

investment letter included in the 2023 UAW collective bargaining

agreement and strongly objects to the union's accusations," the

company said Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Open Lending Q2 revenue beats expectations
Open Lending Q2 revenue beats expectations
Aug 6, 2025
Overview * Open Lending ( LPRO ) Q2 revenue of $25.3 mln beats analyst expectations, per LSEG data * Adjusted EBITDA for Q2 misses analyst estimates, indicating operational challenges * Company repurchased 1.97 mln shares under share repurchase program Outlook * Company expects Q3 certified loans between 22,500 and 24,500 Result Drivers * CERTIFIED LOANS DECLINE - Facilitated 26,522 certified...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Canada's Baylin Technologies Q2 revenue beats expectations
Canada's Baylin Technologies Q2 revenue beats expectations
Aug 6, 2025
Overview * Baylin ( BYLTF ) Q2 revenue rises 1.9% yr/yr to CAD 22.5 mln, beating expectations, per LSEG data * Net income of CAD 1.0 mln in Q2, reversing a loss from Q2 2024 * Adjusted EBITDA increases 50.9% yr/yr, driven by higher gross profit Outlook * Baylin ( BYLTF ) expects softer second half of 2025 compared to...
Cell-engineering firm MaxCyte Q2 revenue misses analyst estimates
Cell-engineering firm MaxCyte Q2 revenue misses analyst estimates
Aug 6, 2025
Overview * MaxCyte ( MXCT ) Q2 total revenue falls 18% yr/yr, missing analyst expectations * Core business revenue rises 8% yr/yr, but SPL revenue drops significantly * Adjusted EBITDA loss widens, missing analyst expectations, per LSEG data Outlook * MaxCyte ( MXCT ) expects SPL Program-related revenue of $5 mln for 2025 * Company anticipates ending 2025 with at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved